Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Emergent Biosolutions Inc. (EBS) had Stock-Based Compensation of $6.10M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$140.90M |
|
$-12.00M |
|
$66.90M |
|
$74.00M |
|
$139.30M |
|
$1.60M |
|
$-18.40M |
|
$-16.80M |
|
$-16.80M |
|
$-12.00M |
|
$-12.00M |
|
$-12.00M |
|
$-12.00M |
|
$1.60M |
|
$27.50M |
|
54.20M |
|
54.20M |
|
$-0.22 |
|
$-0.22 |
|
| Balance Sheet Financials | |
$719.50M |
|
$216.10M |
|
$697.60M |
|
$1.42B |
|
$127.10M |
|
$667.80M |
|
$753.80M |
|
$880.90M |
|
$536.20M |
|
$67.20M |
|
$536.20M |
|
53.70M |
|
| Cash Flow Statement Financials | |
$95.20M |
|
$76.70M |
|
$-6.80M |
|
$105.60M |
|
$271.00M |
|
$165.40M |
|
|
Stock-Based Compensation |
$6.10M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.66 |
|
-- |
|
-- |
|
0.55 |
|
1.25 |
|
52.52% |
|
1.14% |
|
1.14% |
|
-- |
|
-11.92% |
|
-8.52% |
|
$126.90M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
0.20 |
|
1.77 |
|
50.97 |
|
-2.24% |
|
-17.86% |
|
-0.85% |
|
-1.00% |
|
$9.99 |
|
$2.34 |
|
$1.76 |
|